Assessing Target Engagement of Terazosin in Healthy Adults
Latest Information Update: 11 Dec 2023
At a glance
- Drugs Terazosin (Primary)
- Indications Benign prostatic hyperplasia; Hypertension
- Focus Pharmacodynamics
- 05 Dec 2023 Planned number of patients changed from 6 to 18.
- 05 Dec 2023 Planned End Date changed from 30 Apr 2023 to 30 Jun 2024.
- 05 Dec 2023 Status changed from recruiting to active, no longer recruiting.